Crossmark

Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines

Crossref DOI link: https://doi.org/10.1057/s41292-020-00214-4

Published Online: 2021-01-13

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cassier, Maurice https://orcid.org/0000-0003-3908-8073
Funding

Funding for this research was provided by:

European Research Council (340510)
License Information

Text and Data Mining valid from 2021-01-13

Version of Record valid from 2021-01-13
More Information

Article History

Accepted: 22 December 2020

First Online: 13 January 2021

Compliance with ethical standards

:

: The author do not have any competing interests—intellectual or financial—in the research detailed in the manuscript.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below